Stephanie Schuster, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5396 Clauser Rd, Orefield, PA 18069 Phone: 215-208-8141 |
Katherine Burgess, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4670 Cortland Dr, Orefield, PA 18069 Phone: 484-894-5999 |
Margaret Ann Clark, M.S. CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1331 Warba Dr, Orefield, PA 18069 Phone: 610-398-7129 |
News Archive
GlaxoSmithKline announced today updated long-term survival data from two Phase II studies of BEXXAR® (tositumomab and iodine I-131 tositumomab) used in either patients with previously untreated cancer of the immune system (follicular lymphoma) or in patients with cancer of the lymphocytes (non-Hodgkin's lymphoma, NHL) that no longer responded to rituximab.
Since the onset of COVID-19 the potential risk of dental procedure spray emissions for SARS-CoV-2 transmission has challenged care providers and policy makers alike.
A recent study evaluates an immersive virtual reality-based digital intervention to alleviate refractory breathlessness in patients recovering from COVID-19.
The unprecedented challenges posed by the COVID-19 crisis have reached every corner of the globe. While stemming the tragic human toll is still our collective global priority, another looming crisis is coming into view: an alarming increase in those going hungry.
Scientists at the University of California, San Diego have developed a new genetic platform that allows efficient production of naturally occurring molecules, and have used it to produce a novel antibiotic compound.
› Verified 9 days ago